• A
  • A
  • A
日本語 Help
Science and technology information site for articles, patents, researchers information, etc.
Rchr
J-GLOBAL ID:200901090447819047   Update date: Jan. 25, 2025

Habata Toshiya

ハバタ トシヤ | Habata Toshiya
Affiliation and department:
Job title: lecture
Homepage URL  (1): https://www.habata.drt.community/
Research field  (5): Other ,  Construction environment and equipment ,  Control and systems engineering ,  Laboratory animal science ,  Rehabilitation science
Research keywords  (7): cerebral physiology ,  義肢装具学 ,  リハビリテーション・作業療法学 ,  医療・福祉工学 ,  Prosthetics and Orthotics ,  Occupational Therapy ,  Rehabilitation Engineering
Research theme for competitive and other funds  (11):
  • 2022 - 2025 運動と高蛋白質ケトン食の併用による注意欠損多動症の症状改善の試みとその機序解明
  • 2005 - 2007 介護労働における災害を防ぐための介護技術に関する研究
  • 2005 - 2007 A verification of the effects and the research on its diffusion of North European techniques of transfer and movement assistance which prevents lumbago of carers
  • 1999 - 移動・移乗の知識と技術
  • 1999 - The Knowledge of Transfer and Movement Assistance
Show all
Papers (25):
  • There is no royal road to learning. The Journal of Kanagawa Occupational Therapy Research. 2019. 9. 1. 1-6
  • Masakazu Igarashi, Toshiya Habata, Hisanao Akita, Kazuko Noda, Masanori Ogata, Makoto Saji. The NR2B antagonist, ifenprodil, corrects the l-DOPA-induced deficit of bilateral movement and reduces c-Fos expression in the subthalamic nucleus of hemiparkinsonian rats. Neuroscience Research. 2015. 96. 45-53
  • Aki Watanabe, Michinari Fukuda, Makoto Suzuki, Takayuki Kawaguchi, Toshiya Habata, Tsugio Akutsu, Tadashi Kanda. Factors Decreasing Caregiver Burden to Allow Patients with Cerebrovascular Disease to Continue in Long-term Home Care. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES. 2015. 24. 2. 424-430
  • Toshiya HABATA. NR2B antagonist ifenprodil improves abnormal forelimb movement induced by D1R agonist SKF38393 in hemiperkinsonian rats. Kitasato Med J 2015. 2014. 45. 69-79
  • Igarashi M., Habata T. NR2B antagonist ameliorates L-dopa induced dyskinesia via suppressing hyperactivity of subthalamic neurons in hemi-parkinsonian rat. The Journal of Physiological sciences. 2013. 63. suppl. 285
more...
MISC (38):
more...
Books (3):
  • 身体障害作業療法学
    メジカルビュー社 2023 ISBN:9784758320443
  • 生活環境学テキスト
    南江堂 2020 ISBN:9784524227020
  • 移動・移乗の知識と技術 : 援助者の腰痛予防と患者の活動性の向上を目指して
    中央法規出版 2005 ISBN:9784805825808
Lectures and oral presentations  (4):
  • Enrich the environment to empower the brain in the attention-deficit/hyperactivity disorder
    (the 8th Asia Pacific Occupational Therapy Congress 2024 2024)
  • A case of occupational therapy outpatient that help to live with Parkinson's disease
    (The 50th Japanese Occupational Therapy CongressAt: Sapporo (The Japan) 2016)
  • NR2B antagonist ifenprodil improves abnormal forelimb movement induced by D1R agonist SKF38393 in hemiperkinsonian rats
    (International Conference on Parkinsons Disease & Movement Disorders 2015)
  • Prediction of the necessity of the home evaluation in hemiplegic stroke patients.
    (14st international congress and exhibition world confederation for physical therapy 2003)
Works (4):
  • 距離センサーの開発
    2000 -
  • 介護技術
    2000 -
  • 脳卒中患者の復職
    2000 -
  • Return to work of C.V.D patient
    2000 -
Education (4):
  • 2012 - 2015 Kitasato University
  • 1997 - 1999 Nihon University Medical Care-Welfare Engineering
  • 1989 - 1993 Tokyo University of Science Faculty of Engineering electrical engineering
  • 1983 - 1986 Sapporo Medical University Graduate School of Health Sciences Faculty of Rehabilitation
Professional career (1):
  • Ph.D.(Med) (Kitasato University)
Association Membership(s) (6):
Kitasato Medical Society ,  Japanese Society of Structure and Function for Medical Health ,  Rehabilitation Engineering Society of Japan ,  Japanese Society of Occupational Medicine and Traumatology ,  The Japanese Society of Prosthetics and Orthotics ,  Japanese Association of Occupational therapists
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page